Market scenario:
Global Injectable Drug Delivery Devices Market to capture a compound annual growth rate of 11.5% between 2018 and 2023. A wide range of devices fall under the category of injectable drug delivery devices including conventional syringes, needle-free injectors, and auto and pen injectors. Demand for such devices has continued to increase in recent years as they are being used to treatment of medical conditions that witnessing a high prevalence rate. By the year 2023, the global injectable drug delivery devices market is set to surpass a valuation of USD 31,900 Mn.
Advances in design and technology are allowing their usage in more complex delivery procedures. Introduction of next-generation devices with superior functional capabilities is having a positive impact on the global injectable drug delivery devices market. Others factor that can be linked with the market’s growth include increasing prevalence of chronic diseases, growing adoption of self-injectable devices, and rising FDA approvals.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/1211
Global injectable drug delivery devices market is expected to grow at a CAGR of 11.8% during forecasted period.
Key players for global injectable drug delivery devices market
Becton, Dickinson and Company (US), Baxter International (US), Schott AG (Germany), Eli Lilly and Company (US), Pfizer (US), Gerresheimer AG (Germany), Terumo Corporation (Japan), Antares Pharma, Inc. (US), Novo Nordik (Denmark), Sanofi SA (France), Unilife Corporation (US), Zogenix, Inc (US), Hospira, Inc (US), Presage Bioscience (US), MicroCHIPS, Inc (US), Pearl Therapeutics Inc (US), Genentech Inc. (US), Bend Research (US).
Segmentation
Global injectable drug delivery devices market is segmented on the basis of type into devices and formulation. Devices are further segmented into self-injection devices and conventional injection devices. By formulation, they are sub segmented into conventional drug delivery, novel drug delivery and others. On the basis of application, the market is segmented into immune disorder, cancer, diabetes, and other. And on the basis of end users the market is segmented into hospitals, homecare, clinics, and other.
Regional analysis
Global injectable drug delivery devices market is dominated by America owning to increasing patient population suffering from diabetes and cancer. Increasing aging population and technological development is also supporting the growth of the market. Europe accounts second largest market for injectable drug delivery devices which is followed by Asia Pacific. Huge patient population and rapid development of economies in countries of Asia Pacific is the major driver for the market in this region.
Browse Complete 80 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/injectable-drug-delivery-devices-market-1211
Detailed Table Of Contents:
1 Introduction
1.1 Definition
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure:
2 Research Methodology
2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research:
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Macroeconomic Indicators
…Continued!
Send and Enquiry @ https://www.marketresearchfuture.com/enquiry/1211
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
